SCHEMBL16658485

SCHEMBL16658485

c1ccc(-c2nc(-c3ccccc3)nc(-c3cc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)cc(-c4cc(-c5ccccc5)c5c(c4-c4ccccc4)-c4cccc6cccc-5c46)c3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.37
HPGD P15428 6/20 0.37
MAPT P10636 5/20 0.37
MEN1 O00255 5/20 0.37
KMT2A Q03164 5/20 0.37
LMNA P02545 4/20 0.37
KDM4E B2RXH2 3/20 0.37
GLA P06280 1/20 0.37
TSHR P16473 4/20 0.37
MAPK1 P28482 4/20 0.37
HSD17B10 Q99714 3/20 0.37
TP53 P04637 2/20 0.37
CASP1 P29466 1/20 0.37
CASP7 P55210 1/20 0.37
HIF1A Q16665 1/20 0.37
L3MBTL1 Q9Y468 4/20 0.36
ATM Q13315 3/20 0.36
ADORA2A P29274 3/20 0.35
ADORA1 P30542 3/20 0.35
ADORA3 P0DMS8 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16658496 0.94 ALDH1A1 (0.37) ALDH1A1HPGDMAPTMEN1KMT2A
SCHEMBL16658500 0.94 ALDH1A1 (0.42) ALDH1A1HPGDMAPTMEN1KMT2A
SCHEMBL16658480 0.90 MEN1 (0.43) ALDH1A1HPGDMAPTMEN1KMT2A
SCHEMBL16658471 0.89 MEN1 (0.44) ALDH1A1HPGDMAPTMEN1KMT2A
SCHEMBL16859291 0.88 ALDH1A1 (0.44) ALDH1A1HPGDMAPTMEN1KMT2A
SCHEMBL2158220 0.87 ALDH1A1 (0.47) ALDH1A1HPGDMAPTMEN1KMT2A
SCHEMBL16658477 0.87 MEN1 (0.49) ALDH1A1HPGDMAPTMEN1KMT2A
SCHEMBL17014582 0.87 MEN1 (0.49) ALDH1A1HPGDMAPTMEN1KMT2A
SCHEMBL24067908 0.87 MAPT (0.47) ALDH1A1HPGDMAPTMEN1KMT2A
SCHEMBL17014578 0.86 ALDH1A1 (0.43) ALDH1A1HPGDMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10026901-B2 Organic electronic material and organic electroluminescent device GUANGDONG AGLAIA OPTOELECTRONICS MATERIALS CO., LTD (CN) 2018-07-17 US disclosed
US-10026901-B2 Organic electronic material and organic electroluminescent device GUANGDONG AGLAIA OPTOELECTRONICS MATERIALS CO., LTD (CN) 2018-07-17 US disclosed
US-20150108449-A1 ORGANIC ELECTRONIC MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE BEIJING AGLAIA TECHNOLOGY DEVELOPMENT CO., LTD (CN) 2015-04-23 US disclosed
US-20150108449-A1 ORGANIC ELECTRONIC MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE BEIJING AGLAIA TECHNOLOGY DEVELOPMENT CO., LTD (CN) 2015-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150108449-A1 ORGANIC ELECTRONIC MATERIAL AND ORGANIC ELECTROLUMINESCENT DEVICE OCIAD1, OCIAD2, SLCO4C1 ALDH1A1 1789/4885HPGD 1464/4885MAPT 300/4885
US-10026901-B2 Organic electronic material and organic electroluminescent device OCIAD1, OCIAD2, SLCO4C1 ALDH1A1 1789/4885HPGD 1464/4885MAPT 300/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.